1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - A potential pathway affecting proliferation
(
- Contribution to journal › Article
-
Mark
Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes
(
- Contribution to journal › Article
-
Mark
Uncontrolled asthmatics have increased FceRI+ and TGF-β–positive MCTC mast cells and collagen VI in the alveolar parenchyma
(
- Contribution to journal › Article
- 2016
-
Mark
5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo
(
- Contribution to journal › Article
- 2015
-
Mark
ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling.
2015) In Laboratory Investigation(
- Contribution to journal › Article
- 2011
-
Mark
Infection and remodelling: a 21st century model of bronchiectasis?
(
- Contribution to journal › Debate/Note/Editorial
- 2009
-
Mark
Allergic Airway Inflammation Initiates Long-Term Vascular Remodeling of the Pulmonary Circulation.
(
- Contribution to journal › Article
- 2008
-
Mark
Remodeling of extra-bronchial lung vasculature following allergic airway inflammation.
(
- Contribution to journal › Article
- 2006
-
Mark
Direct evidence of secondary necrosis of neutrophils during intense lung inflammation.
(
- Contribution to journal › Article
-
Mark
Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation.
(
- Contribution to journal › Article